294. 先天性横隔膜ヘルニア Congenital diaphragmatic hernia Clinical trials / Disease details


臨床試験数 : 15 薬物数 : 36 - (DrugBank : 6) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-002026-22-NL
(EUCTR)
24/10/201327/06/2013Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm.Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC GORD,;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Trade Name: Losec
Product Name: Omeprazol
Product Code: NA
Trade Name: Losec
Product Name: Omeprazol
Product Code: NA
ErasmusMCNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands
2NCT00226044
(ClinicalTrials.gov)
September 200522/9/2005Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.Gastroesophageal Reflux;Esophageal Atresia;Hernia, DiaphragmaticDrug: Omeprazole rectally 1mg/kgRijnstate HospitalErasmus Medical CenterCompleted6 Weeks3 MonthsAll17Phase 3Netherlands